This mechanism indicates that ALKBH5 may reduce the m6A level of YAP1 precursor mRNA in NSCLC, thus affecting the Hippo/YAP1 pathway [124]. This evidence concerns the gene ALKBH5 and non-small cell lung carcinoma.